The cumulative incidence of and risk factors for latent beaking in patients with autoimmune diseases taking long-term glucocorticoids and bisphosphonates

The fracture sites of atypical femoral fractures are associated with the weight-bearing lower limb alignment

(2014) Yoshitomo Saita et al.   BONE

Absence of femoral cortical thickening in long-term bisphosphonate users: Implications for atypical femur fractures

(2014) Foster Chen et al.   BONE

The incidence of and risk factors for developing atypical femoral fractures in Japan

(2014) Yoshitomo Saita et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research: 2014 update

(2014) Yasuo Suzuki et al.   JOURNAL OF BONE AND MINERAL METABOLISM

Glucocorticoids and bone: local effects and systemic implications

(2014) Holger Henneicke et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research

(2013) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday

(2012) Michael McClung et al.   AMERICAN JOURNAL OF MEDICINE

Increasing Occurrence of Atypical Femoral Fractures Associated With Bisphosphonate Use

(2012) Raphael P. H. Meier et al.   ARCHIVES OF INTERNAL MEDICINE

Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls

(2012) Jörg Schilcher et al.   BONE

Glucocorticoid-Induced Osteoporosis and Osteonecrosis

(2012) Robert S. Weinstein   ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA

Incidence and demography of femur fractures with and without atypical features

(2012) Adrianne C Feldstein et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Atypical Subtrochanteric Femur Fracture in Patient with Metastatic Breast Cancer Treated with Zoledronic Acid

(2012) Yong-Seok Kim et al.   Journal of Breast Cancer

The conundrum of glucocorticoid-induced osteoporosis

(2012) Steven L. Teitelbaum   Nature Reviews Endocrinology

Treatment of Femoral Fracture Nonunion After Long-term Bisphosphonate Use

(2012) Mary K. Grady et al.   ORTHOPEDICS

Bisphosphonate-associated atypical fracture of the femur: Spontaneous healing with drug holiday and re-appearance after resumed drug therapy with bilateral simultaneous displaced fractures — a case report

(2011) Ken Lee Puah et al.   Acta Orthopaedica

Bisphosphonate Use and the Risk of Subtrochanteric or Femoral Shaft Fractures in Older Women

(2011) Laura Y. Park-Wyllie   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Evolution of bisphosphonate-related atypical fracture retrospectively observed with DXA scanning

(2011) Mark A Ahlman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis?

(2010) Steven L. Teitelbaum et al.   ARTHRITIS AND RHEUMATISM

Glucocorticoids Suppress Bone Formation by Attenuating Osteoblast Differentiation via the Monomeric Glucocorticoid Receptor

(2010) Alexander Rauch et al.   Cell Metabolism

Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research

(2010) Elizabeth Shane et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Atypical Femoral Fractures and Bisphosphonate Use

(2010) Christian M. Girgis et al.   NEW ENGLAND JOURNAL OF MEDICINE